Sara Salama

Sara Salama

Auto-generated profile, based on publicly available information

Sara Salama

Alexandria University Faculty of Medicine, Department of Neurology, Alexandria, Egypt; Department of Neuroinflammation, Queen Square Multiple Sclerosis, University College London, London, UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
RNRam Narayan
Ram Narayan
ASAlexandra Simpson
Alexandra Simpson
KFKatelyn Fritsche
Katelyn Fritsche
SSSara Salama
Sara Salama
SPSantiago Pardo
Santiago Pardo
MLMichael Levy
Michael Levy

15 January 2020 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
PDF file
SSSara Salama
Sara Salama
MKMajid Khan
Majid Khan
ASAmirali Shanechi
Amirali Shanechi
MLMichael Levy
Michael Levy
IIIzlem Izbudak
Izlem Izbudak
Background: MOG antibody and AQP4 antibody seropositive diseases are immunologically distinct subtypes of neuromyelitis optica spectrum disorders (NMOSD) with similar clinical presentations. MRI findings can be instrumental in distinguishing MOG antibody disease from AQP4 antibody NMOSD. Objectives: The aim of this study is to characterize the neuroradiological differences between MOG antibody disease and AQP4 antibody NMOSD with the aim to distinguish between the two entities. Methods: This is a retrospective study of 26 MOG and 25 AQP4 seropositive patients in which MRI features of the brain, spinal cord, and orbit were compared. Results: The majority of the abnormal findings in the MOG cohort were located on orbital MRIs, while spinal cord magnetic resonance (MR) abnormalities were more common in the AQP4 cohort. Brain abnormalities showed some overlap, but cortical gray/juxtacortical white matter involvement was distinct to MOG patients, while area postrema involvement was a rare feature. Conclusion: Cortical gray/juxtacortical white matter lesions on brain MRI might help distinguish MOG antibody disease from AQP4-positive NMOSD. These findings could be of value in distinguishing the two entities as early as the first presentation.

12 August 2021 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
IIIsmail Ibrahim Ismail
Ismail Ibrahim Ismail
SSSara Salama
Sara Salama

1 April 2019 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
SSSara Salama
Sara Salama
MKMajid Khan
Majid Khan
MLMichael Levy
Michael Levy
IIIzlem Izbudak
Izlem Izbudak

1 November 2018 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
SSSara Salama
Sara Salama
HMHazem Marouf
Hazem Marouf
MRM. Ihab Reda
M. Ihab Reda
AMAmal R. Mansour
Amal R. Mansour
OEOsama Elkholy
Osama Elkholy
MLMichael Levy
Michael Levy

1 May 2019 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
SSSara Salama
Sara Salama
SPSantiago Pardo
Santiago Pardo
MLMichael Levy
Michael Levy